cgt2009, You posted: Quote: "A $150M market capped company with $231M coming our way over the next few years to develop a product for a guaranteed market worth $billions".
You and PC blamed the stupid market for not understanding Biota.
The seasonal antiviral market is worth a $BILLION a year. This is not the pandemic stockpile. It is a guaranteed market sometimes above a Billion sometimes below it.
You can easily benchmark Relenza sales against Tamiflu. Peter Cook was giving excuses for GSK by telling shareholders not to worry when Relenza drops off the news.
What percentage of the "guaranteed market worth $billions" will the product gain with PC as CEO? With all the problems with Tamiflu, the last 2 quarters of Relenza sales to Europe is ZERO. Please explain on behalf of PC why the sales is ZERO and what is PC going to do about it especially when he collected 0.5 million of free oopies for normalising relationship with GSK.
BTA Price at posting:
79.0¢ Sentiment: LT Buy Disclosure: Held
